Abstract
Although invasive pulmonary aspergillosis (IPA) is typically described in immunocompromised host, patient with severe influenzae can develop IPA. Similarly, patients with severe COVID-19 complicated with IPA are increasingly reported. Here, we describe a case of invasive aspergillosis with triazole-resistant A. fumigatus (TR34/L98H mutation) in a 56-year-old patient with COVID-19 in intensive care unit. This report highlights the need to define the available tools for diagnosis of invasive aspergillosis in severe COVID-19 patients.
All Keywords
【저자키워드】 COVID-19, coronavirus, SARS-CoV2, ICU, aspergillosis, Triazole-resistance, 【초록키워드】 Mutation, intensive care, severe COVID-19, Diagnosis, Patient, Immunocompromised, severe COVID-19 patients, A. fumigatus, Host, patient with COVID-19, IPA, invasive, highlight, described, develop, reported, to define, increasingly, 【제목키워드】 Case report, Aspergillus fumigatus, COVID-19 patient, specimen,
【저자키워드】 COVID-19, coronavirus, SARS-CoV2, ICU, aspergillosis, Triazole-resistance, 【초록키워드】 Mutation, intensive care, severe COVID-19, Diagnosis, Patient, Immunocompromised, severe COVID-19 patients, A. fumigatus, Host, patient with COVID-19, IPA, invasive, highlight, described, develop, reported, to define, increasingly, 【제목키워드】 Case report, Aspergillus fumigatus, COVID-19 patient, specimen,